Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

BACKGROUND: During stavudine phase-out plan in developing countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofovir/lamivudine/efavirenz and tenofovir/lamivudine/nevirapine is lacking. METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Manosuthi, Weerawat, Mankatitham, Wiroj, Lueangniyomkul, Aroon, Prasithsirikul, Wisit, Tantanathip, Preecha, Suntisuklappon, Busakorn, Narkksoksung, Anongnuch, Nilkamhang, Samruay, Sungkanuparph, Somnuek
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020664/
https://ncbi.nlm.nih.gov/pubmed/20937122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-37
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados